We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.
- Authors
Fisher, Richard I; Bernstein, Steven H; Kahl, Brad S; Djulbegovic, Benjamin; Robertson, Michael J; de Vos, Sven; Epner, Elliot; Krishnan, Amrita; Leonard, John P; Lonial, Sagar; Stadtmauer, Edward A; O'Connor, Owen A; Shi, Hongliang; Boral, Anthony L; Goy, André
- Abstract
Evaluate response rate, duration of response (DOR), time-to-progression (TTP), overall survival (OS), and safety of bortezomib treatment in patients with relapsed or refractory mantle cell lymphoma (MCL).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Vol 24, Issue 30, p4867
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.07.9665